1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Global Therapeutic Vaccines Market Growth, Trends & Forecast (2016 - 2021)

Global Therapeutic Vaccines Market Growth, Trends & Forecast (2016 - 2021)

  • August 2016
  • -
  • Mordor Intelligence LLP
  • -
  • 208 pages

The global therapeutic vaccines market was valued at USD 11 billion in 2015 and is projected to reach USD 51 billion by 2021, at a CAGR of 29% during the forecast period. The increasing prevalence of chronic diseases such as cancer and HIV/AIDS are fueling the market growth.

Market Dynamics

The favorable funding for R&D, increasing investments by companies, and rise in the prevalence of chronic diseases are some of the factors that are propelling the growth of the market. However, high costs of the vaccines and stringent regulatory guidelines are turning out to be restraints for this market.

Market Segmentation

The global therapeutic vaccines market has been segmented by type and geography.

Type -

Auto Immune Diseases Vaccines
Neurological Disease Vaccines
Cancer Vaccines
Infectious Diseases Vaccines
The cancer vaccines sub-segment contributes the highest share.

Geography -

North America
Europe
Asia-Pacific
Latin America
The Middle East and Africa
North America has the largest market size, followed by Europe. Asia-Pacific is considered to be an emerging market for vaccines due to the rising population and large investments in the field of research and development.

Many players in this market are trying to expand their product portfolio to top the global market. Few companies have adopted product innovation and new product launches as their key business strategies to ensure their dominance in the market.

The major players in the therapeutic vaccines market are:

Agenus Inc.
Bavarian Nordic
Celtic Pharma
Cytos Biotechnology
Dendreon Corp
GlaxoSmithKline
Pfizer
Merck Serono
Novartis
Transgene


Key Deliverables in the Study

Market analysis for the global therapeutic vaccines market, with region specific assessments and competition analysis.
Market definition along with the identification of key drivers, restraints, opportunities and challenges.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.
Identification and analysis of the macro and micro factors that affect the global therapeutic vaccines market.
Insights of the market in the regions that have the highest potential for growth and also to identify the markets that are still untapped

Table Of Contents

Global Therapeutic Vaccines Market Growth, Trends and Forecast (2016 - 2021)
1. Introduction

1.1 Study Deliverables

1.2 Market Definition

1.3 General Study Assumptions

1.4 Report Description

2. Research Methodology

2.1 Introduction

2.2 Analysis Methodology

2.3 Study timeline

2.4 Study Phases

2.4.1 Secondary Research

2.4.2 Discussion Guide

2.4.3 Market Engineering and Econometric Model

2.4.4 Expert Validation

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry trends

5.1 Current Market Scenario

5.2 Porter's Five Force Analysis

5.2.1 Bargaining Power of Suppliers

5.2.2 Bargaining Power of Consumers

5.2.3 Threat to New Entrants

5.2.4 Threat to Substitute Products and Services

5.2.5 Competitive Rivalry Within the Industry

6. Market Drivers, Restraints, Opportunities, and Challenges Analysis

6.1 Market Drivers

6.1.1 Favorable Government Funding for Vaccine Development

6.1.2 Increasing Investments by Companies

6.1.3 Rising Prevalence of Disease

6.2 Market Restraints

6.2.1 High Cost of Vaccines

6.2.2 Stringent Regulatory Guidelines

6.3 Market Ppportunities

6.4 Market Challenges

7. Market Segmentation

7.1 By Type

7.1.1 Auto Immune Disease Vaccines

7.1.2 Neurological Disease Vaccines

7.1.2.1 ACC-001

7.1.2.2 CAD 106

7.1.2.3 Parkinson's Vaccine

7.1.2.4 Alzheimer's Vaccine

7.1.3 Cancer Vaccines

7.1.3.1 Multikine

7.1.3.2 PR1 Peptide

7.1.3.3 Trovax

7.1.3.4 CYT004-MelQbG10

7.1.4 Infectious Disease Vaccines

7.1.4.1 Hepatitis C Vaccines

7.1.4.2 HIV/AIDS Vaccine

7.1.4.3 Other Infectious Disease Vaccines

7.2 By Geography

7.2.1 North America

7.2.1.1 USA

7.2.1.2 Canada

7.2.1.3 Mexico

7.2.2 Europe

7.2.2.1 Germany

7.2.2.2 France

7.2.2.3 UK

7.2.2.4 Italy

7.2.2.5 Spain

7.2.2.6 Scandinavia

7.2.2.7 BENELUX

7.2.2.8 Rest of Europe

7.2.3 Asia-Pacific

7.2.3.1 Japan

7.2.3.2 China

7.2.3.3 India

7.2.3.4 South Korea

7.2.3.5 Australia and New Zealand

7.2.3.6 Rest of Asia-Pacific

7.2.4 Middle East and Africa

7.2.4.1 GCC

7.2.4.2 South Africa

7.2.4.3 Rest of Middle East and Africa

7.2.5 South America

7.2.5.1 Brazil

7.2.5.2 Argentina

7.2.5.3 Rest of South America

8. Competitive Landscape

8.1 Mergers and Acquisitions Analysis

8.2 Collaborationa and Partnerships

8.3 New Product Launches

9. Key Vendor Analysis

9.1 Agenus Inc

9.2 Bavarian Nordic

9.3 Celtic Pharma

9.4 Cytos Biotechnology

9.5 Dendreon Corp

9.6 GlaxoSmithKline

9.7 Pfizer

9.8 Merck Serono

9.9 Novartis

9.10 Transgene

10. Future Outlook of the Marke

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...


Download Unlimited Documents from Trusted Public Sources

Diabetes Statistics

  • February 2017
    4 pages
  • Diabetes  

    Depression  

    Mental Health  

View report >

Blood Supply Industry in Namibia and Africa

  • February 2017
    209 pages
  • Health Care Pro...  

    Blood Supply  

    HIV AIDS  

  • Namibia  

    Africa  

    World  

View report >

Influenza Statistics

  • February 2017
    119 pages
  • Influenza  

    Hospital  

View report >

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.